Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,106	1,870	596	242	364	885
Market Cap Growth	555.73%	213.80%	146.75%	-33.65%	-58.88%	-60.92%
Enterprise Value	1,720	1,585	379.01	40.14	134.43	665.48
Last Close Price	35.61	31.74	11.03	5.26	9.23	23.99
PE Ratio	-	-264.50	-6.68	-2.21	-3.55	-10.25
PS Ratio	11.42	10.14	16.30	27.51	29.35	-
PB Ratio	5.95	5.31	2.60	1.51	1.97	4.07
P/TBV Ratio	5.86	5.33	2.60	1.45	1.94	4.05
P/FCF Ratio	46.90	41.64	-6.85	-2.92	-10.16	-13.00
P/OCF Ratio	46.21	41.03	-6.86	-2.98	-11.42	-13.23
EV/Sales Ratio	9.32	8.59	10.37	4.57	10.84	-
EV/EBITDA Ratio	-	-84.22	-3.82	-0.36	-1.31	-7.82
EV/EBIT Ratio	-	-76.98	-3.74	-0.35	-1.29	-7.73
EV/FCF Ratio	38.29	35.29	-4.35	-0.49	-3.75	-9.77
Net Debt / Equity Ratio	-0.81	-0.81	-0.95	-1.26	-1.24	-1.01
Net Debt / EBITDA Ratio	15.15	15.15	2.19	1.79	2.23	2.58
Net Debt / FCF Ratio	-6.35	-6.35	2.49	2.44	6.41	3.23
Asset Turnover	0.53	0.53	0.15	0.04	0.05	0
Quick Ratio	5.06	5.06	5.48	6.54	7.33	12.83
Current Ratio	5.28	5.28	5.81	6.99	7.77	13.37
Return on Equity (ROE)	-2.37%	-2.37%	-45.80%	-60.80%	-50.20%	-34.06%
Return on Assets (ROA)	-5.97%	-5.97%	-40.56%	-47.39%	-42.17%	-32.07%
Return on Invested Capital (ROIC)	-34.09%	-34.09%	-451.00%	-1072.85%	-1757.72%	-15535.20%
Return on Capital Employed (ROCE)	-6.96%	-6.96%	-47.26%	-54.37%	-46.75%	-33.87%
Earnings Yield	-0.33%	-0.38%	-14.96%	-45.25%	-28.17%	-9.75%
FCF Yield	2.13%	2.40%	-14.61%	-34.23%	-9.84%	-7.69%
Buyback Yield / Dilution	-9.65%	-9.65%	-22.76%	-13.10%	-5.87%	-9.71%
Total Shareholder Return	-9.65%	-9.65%	-22.76%	-13.10%	-5.87%	-9.71%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q